axogen · 3 hours ago
Treasury Analyst
Axogen is committed to building a strong company culture that fosters professional growth. The Treasury Analyst supports the company’s treasury operations by preparing, processing, and tracking cash and investment activities, while collaborating across Finance and Accounting teams.
BiotechnologyMedicalMedical Device
Responsibilities
Support daily cash operations, including bank account monitoring, wire transfers, and check deposits
Prepare daily cash receipt reports
Reconcile investment accounts monthly
Review and analyze monthly/quarterly bank service charges, credit facilities, and interest expense
Collaborate with Accounting and FP&A to provide reporting support for senior management
Maintain and reconcile stock option activity (grants, exercises, cancellations) for compliance and accurate reporting
Partner with Legal on employee trading plans and open trading windows
Assist with quarterly and annual reporting, including year-end proxy reporting
Identify and recommend process improvements
Perform ad hoc reporting and analysis as needed
Qualification
Required
Bachelor's degree in Finance or related field
3 years of financial experience in a corporate setting
Strong communication (written and oral) and interpersonal skills
High attention to detail and problem-solving ability
Proficiency in Microsoft Office; advanced Excel skills required
Preferred
Experience with accounting software (e.g., Great Plains) a plus
Benefits
Health
Dental
Vision
Matching 401K
Paid Time Off
9 Paid Holidays + 3 Floating Holidays
Dependent Care Flexible Spending Accounts
Medical Flexible Spending Accounts
Tuition Reimbursement
Paid Parental Leave
Paid Caregiver Leave
Basic Life Insurance
Supplemental Life Insurance
Employee Stock Purchase Plan
Disability Insurance
Company
axogen
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Funding
Current Stage
Public CompanyTotal Funding
$131.92MKey Investors
PDL Biopharma
2017-11-15Post Ipo Equity· $41M
2015-08-28Post Ipo Equity· $17.5M
2015-02-05Post Ipo Equity· $13M
Recent News
2025-12-05
2025-12-05
2025-12-04
Company data provided by crunchbase